Abiopharma

🔍 Slavtcheff Craig (Executive)

Company: KIMBERLY CLARK CORP (KMB)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 1,257 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,152.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 535 shares of Common Stock at $97.67 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,617.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,257 shares of Restricted Share Units 5/01/2025 (w/dividends reinvested) (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,934.00 | transaction_form_type: 4 | Footnotes: F2, F1, F2, F4, F4
• Acquired 5,324 shares of Restricted Share Units 5/1/2026 (w/dividends reinvested) (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,324.00 | transaction_form_type: 4 | Footnotes: F2, F2, F4, F4

Footnotes:

• F1: Represents restricted share units that have vested and are paid out in shares of common stock. Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.
• F2: Restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.
• F3: This transaction represents the automatic surrender of shares to the issuer upon vesting of restricted shares units to satisfy the reporting person's tax withholding obligations.
• F4: The restricted share units vest 30 percent on each of the first and second anniversaries of the grant date and the remaining 40 percent on the third anniversary of the grant date.